These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12883318)

  • 1. Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure.
    Adamson PB; Vanoli E; Mattera GG; Germany R; Gagnol JP; Carminati P; Schwartz PJ
    J Cardiovasc Pharmacol; 2003 Aug; 42(2):169-73. PubMed ID: 12883318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure.
    Sabbah HN; Imai M; Cowart D; Amato A; Carminati P; Gheorghiade M
    Am J Cardiol; 2007 Jan; 99(2A):41A-46A. PubMed ID: 17239704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
    Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure.
    Tanimura M; Mishima T; Steinberg MI; Borzak S; Goldstein S; Sabbah HN
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):77-82. PubMed ID: 10755204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
    Juillière Y; Feldmann L; Perrin O; Berder V; Danchin N; Cherrier F
    Int J Cardiol; 1995 Nov; 52(1):17-22. PubMed ID: 8707430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
    Shen W; Gill RM; Jones BD; Zhang JP; Corbly AK; Steinberg MI
    J Pharmacol Exp Ther; 2002 Nov; 303(2):673-80. PubMed ID: 12388650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of critical coronary stenosis on global systolic left ventricular function quantified by pressure-volume relations during dobutamine stress in the canine heart.
    Steendijk P; Baan J; Van der Velde ET; Baan J
    J Am Coll Cardiol; 1998 Sep; 32(3):816-26. PubMed ID: 9741532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
    Liang CS; Thomas A; Imai N; Stone CK; Kawashima S; Hood WB
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):509-16. PubMed ID: 2447398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.
    Gheorghiade M; Blair JE; Filippatos GS; Macarie C; Ruzyllo W; Korewicki J; Bubenek-Turconi SI; Ceracchi M; Bianchetti M; Carminati P; Kremastinos D; Valentini G; Sabbah HN;
    J Am Coll Cardiol; 2008 Jun; 51(23):2276-85. PubMed ID: 18534276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
    Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
    Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
    Blair JE; Macarie C; Ruzyllo W; Bacchieri A; Valentini G; Bianchetti M; Pang PS; Harinstein ME; Sabbah HN; Filippatos GS; Gheorghiade M;
    Am J Ther; 2008; 15(3):231-40. PubMed ID: 18496261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic and lusitropic effects of incremental doses of dobutamine in dogs with right ventricular apical pacing-induced cardiac dysfunction.
    Nakata TM; Kaji H; Matsuura N; Shimizu M; Tanaka R
    J Vet Pharmacol Ther; 2019 May; 42(3):285-293. PubMed ID: 30724383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
    Kerbaul F; Rondelet B; Demester JP; Fesler P; Huez S; Naeije R; Brimioulle S
    Crit Care Med; 2006 Nov; 34(11):2814-9. PubMed ID: 16971854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of OPC-8212, a new positive inotropic agent, and dobutamine on left ventricular global and ischemic regional functions and coronary hemodynamics under coronary artery stenosis.
    Maruyama Y; Nishioka O; Watanabe J; Keitoku M; Satoh S; Isoyama S; Ashikawa K; Ino-Oka E; Takishima T
    J Cardiovasc Pharmacol; 1986; 8(1):161-9. PubMed ID: 2419680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.